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REDD1 is induced by various cellular stresses; however, its expression in response to lipopolysaccha-
ride (LPS) has not been clearly elucidated in immune cells. LPS stimulated CREB-dependent and
NF-jB-independent REDD1 expression in macrophages. Early increases in CREB phosphorylation
and REDD1 expression at 8 h following LPS treatment were blocked by inhibition of p38MAPK
and mitogen- and stress-activated protein kinase 1 (MSK1), but not PKA. However, delayed
CREB-mediated REDD1 expression at 16 h was suppressed by inhibition of cyclooxygenase-2
(COX-2) and PKA. It indicates that LPS induces REDD1 expression by two distinct CREB-mediated
mechanisms, the early p38MAPK/MSK1 and the delayed COX-2/PGE2/PKA pathways.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction associated with cell survival and proliferation, transformationLipopolysaccharide (LPS) is a potent inflammatory inducer that
elicits inflammatory responses through transcriptional induction
of many cytokines, chemokines and inflammatory enzymes,
including tumor necrosis factor-a, interleukin (IL)-1b, inducible
nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2).
LPS-induced inflammatory gene expression is generally mediated
by activation of MAPK and the transcription factor nuclear
factor-jB (NF-jB) via ligation of its receptor Toll-like receptor 4
[1]. NF-jB can also induce several non-inflammatory genesand angiogenesis [2].
Regulated in development and DNA damage response 1 (REDD1,
also known as RTP801/Dig2/DDIT4) was initially identified as
novel stress response gene [3–5] and exerts several functions in
cells exposed to stress conditions. Indeed, hypoxia- and
glucocorticoid-induced REDD1 is known to play an important role
in the TSC1/TSC2-mediated inhibition of mTOR, a central regulator
of protein translation [6], resulting in inhibition of cell survival and
growth [6,7]. On the other hander, REDD1 expressed in RAS-
transfected ovarian epithelial cells is an essential mediator in
RAS-mediated malignant transformation via promotion of cell sur-
vival and growth by counter-regulation of pro- and anti-apoptotic
gene expression [8]. In addition, abnormal expression of REDD1 is
involved in various diseases, including Alzheimer’s disease [9] and
oxygen-induced retinopathy [10].
REDD1 is transcriptionally induced in various types of cells by
DNA damage, reactive oxygen species, endoplasmic reticulum
stress, apoptotic signals, and hypoxia [4–6,11]. Transcriptional
activation of REDD1 is usually mediated by several transcription
factors, such as p53 and hypoxia-responsive transcription factor
2860 D.-K. Lee et al. / FEBS Letters 589 (2015) 2859–2865hypoxia-inducible factor 1 (HIF-1) [3,4]. It has been also demon-
strated that transcriptional REDD1 expression during oxidative
and ER stress is elicited by cooperative binding of ATF4 and C/
EBP-b to the C/EBP consensus site in the REDD1 promoter
[11,12]. Moreover, a recent study showed that LPS administration
induced REDD1 expression in alveolar epithelial cells and lung
inflammation, which was significantly attenuated in REDD1/
mice [13]. It suggests that REDD1 plays an important role in
inflammatory response under some pathological conditions,
including sepsis and endotoxemia. However, REDD1 expression
and its underlying mechanism have not been studied in LPS-
stimulated macrophages.
In this study we found that REDD1 was induced in macrophages
stimulated with LPS via two different mechanisms, the early
p38MAPK/MSK1/CREB axis and the delayed cAMP/PKA/CREB sig-
naling pathway via COX-2-mediated PGE2 synthesis.
2. Materials and methods
2.1. Reagents and chemicals
Cell culture media and supplements were purchased from
Thermo Fisher Scientific Inc. (Waltham, MA). Antibody for REDD1
was obtained from ProteinTech Group (Chicago, IL, USA).
Antibodies for p-p38, p-MSK1, and CREB were obtained from Cell
Signaling Technology (Beverly, MA). Antibodies for MSK1,
p38MAPK, NF-jB p65, NF-jB c-Rel, and siRNAs targeting mouse
NF-jB p65, NF-jB c-Rel, and MSK1 were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibodies for p-CREB and
iNOS were obtained from Millipore (Temecula, CA) and BD
Biosciences (San Diego, CA), respectively. LPS (Escherichia coli
O111:B4), SB203580, SP600125, db-cAMP, NS398, and antibody
for b-actin were obtained from Sigma (St. Louis, MO). Bay11-
7082 and myristoylated PKI (14–22) amide were purchased from
Enzo Life Science (Farmingdale, NY). PD98059 and Ro318220 were
obtained from Calbiochem (San Diego, CA).
2.2. Cell culture
Peritoneal macrophages were collected from the peritoneal cav-
ity of 6 to 8-week-old male BALB/c mice (OrientBio, Sungnam,
Korea) given i.p. injections of 1.5 ml of 4% thioglycollate broth
4 days before harvest. Peritoneal macrophages and murine macro-
phage RAW264.7 cells were cultured in DMEM (100 units/ml peni-
cillin, 100 mg/ml streptomycin, 25 mM HEPES) containing 5% fetal
bovine serum at 37 C under 5% CO2/95% air. Cells were treated
with LPS (1 lg/ml), PGE2 (10 lM) or db-cAMP (300 lM) in the
presence or absence of various chemical inhibitors and also trans-
fected with 100 nM scrambled, NF-jB p65, c-Rel, and MSK1 siRNAs
using a microporator.
2.3. Western blot analysis
Cells were lysed in RIPA buffer and the lysates were separated
by SDS–PAGE and transferred to polyvinylidene difluoride mem-
branes. The membranes were incubated with antibodies against
target proteins for 2 h. After washing twice, the membranes were
incubated with a horseradish peroxidase-conjugated secondary
antibody, and protein levels were detected by an enhanced chemi-
luminescence system as previously described [14].
2.4. Promoter vector construction and luciferase assay
REDD1 promoter (1.5 kb) was prepared from genomic DNA
isolated from RAW264.7 cells by PCR using primers (sense: 50-GGTCTCGAGAAATATCGGTGGTAGGAG-30; anti-sense: 50-AATAAGCTT
CGGACCTGTCCCTTCGAA-30). REDD1 promoter was cloned into
the XhoI and HindIII sites of the pGL3-basic vector (pREDD1).
REDD1 promoter containing mutant CRE site was also cloned into
the pGL3 vector (pREDD1-mCRE). Macrophages (1  106 cells)
were co-transfected with 1 lg of pREDD1 construct or
p5xNF-jB-Luc along with 1 lg of b-gal expression vector by micro-
poration. Transfected cells were stabilized overnight in DMEM
media containing 10% FBS. After treatments with various
chemicals, cells were lysed with passive lysis buffer, and luciferase
activity was assayed using the Luciferase Assay System (Promega).
The relative luciferase units were normalized to b-galactosidase
activity.
2.5. Chromatin immunoprecipitation (ChIP)
RAW264.7 cells were treated with 1 lg/ml LPS or 300 lM
db-cAMP for 1 h after pretreatment with various chemical inhibi-
tors or transfection with MSK1 siRNA for 1 or 24 h. DNA/protein
cross-linking was obtained by incubating cells for 20 min at 37 C
in 1% formaldehyde. After sonication, chromatin was immunopre-
cipitated overnight with 10 ll of phosphor-CREB antibody. After
DNA extraction, targeted promoter sequences of REDD1 were iden-
tified by PCR using primer pairs (50-GATGCTCATGGGACAACGGA-30
and 50-GGTACCCCTAGCTTCTGGGA-30) spanning REDD1 promoter
regions containing the CREB binding sequence. The products
(118 bp) were identified on a 2% agarose gel.
2.6. Quantitative real-time RT-PCR (qRT-PCR)
cDNA was synthesized from 1 lg of total RNA isolated from
macrophages using an M-MLV reverse transcriptase (Promega)
according to the manufacturer’s protocol. qRT-PCR for mouse
REDD1 and GAPDH mRNAs was performed using SYBR Green
Master Mix (Applied Biosystems) with gene-specific primers in a
Rotar-Gene (Qiagen). The threshold cycle difference for gene tran-
scripts was calculated by 2DDCT general method using GAPDH as
an internal control. The primers used were as follows: 50-CACCTG
TGTGCCAACCTGAT-30 (forward) and 50-AGTTCCTTGCCCACCTGG-30
(reverse) for REDD1; 50-CAAAATGGTGAAGGTCGGTG-30 (forward)
and 50-GAGGTCAATGAAGGGGTCGT-30 (reverse) for GAPDH.
2.7. Measurements of NO and PGE2
NO and PGE2 levels were measured in culture media using
Griess reagents and an ELISA kit (R&D systems), respectively.
2.8. Statistical analysis
Quantitative data are expressed as mean ± standard deviation
(S.D.) of at least three separate experiments. Statistical significance
was determined using the unpaired Student’s t test, depending on
the number of experimental groups analyzed. Significance was
established at a P value < 0.05.
3. Results
3.1. LPS induces REDD1 expression in macrophages
We first examined whether LPS regulates REDD1 expression in
macrophages. Treatment with LPS resulted in significant increases
in REDD1 mRNA and protein levels in murine macrophage cell line
RAW264.7 cells at 4 h, as compared with control, and these
increases were further elevated until 8 h (Fig. 1A). To investigate
whether LPS regulates REDD1 transcriptional activity, RAW264.7
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Fig. 1. LPS induces REDD1 expression in macrophages. (A) RAW264.7 cells were stimulated with LPS (1 lg/ml) for the indicated time periods. Levels of REDD1 mRNA and
protein were determined by qRT-PCR (n = 3) and immunoblotting. *P < 0.05 and **P < 0.01. (B) RAW264.7 cells were transfected with mock vector and REDD1 promoter
plasmid (pREDD1) and stimulated with or without LPS for 12 h. Luciferase activity was measured in cell lysates by a luminometer (n = 3). **P < 0.01 vs. non-stimulated control.
(C) Peritoneal macrophages were stimulated with LPS (1 lg/ml) for 8 h. Levels of REDD1 mRNA and protein were determined by qRT-PCR and immunoblotting. ***P < 0.001 vs.
non-stimulated control. (D) Peritoneal macrophages transfected with mock vector and REDD1 promoter plasmid (pREDD1) were stimulated with or without LPS for 12 h.
Luciferase activity was measured in the cell lysates (n = 3). **P < 0.01 vs. non-stimulated control.
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construct (1.5 kb) and stimulated with LPS. Treatment with LPS
resulted in a 7.3-fold increase in REDD1 promoter activity, as
compared with non-stimulated cells (Fig. 1B), indicating that LPS
transcriptionally activates REDD1 expression. Similarly, LPS stimu-
lation of primary peritoneal macrophages increased REDD1 mRNA
and protein levels at 8 h, as compared with non-stimulated control
(Fig. 1C). In addition, treatment with LPS significantly increased
REDD1 promoter activity in mouse peritoneal macrophages, com-
pared with non-stimulated macrophages (Fig. 1D). These findings
indicate that LPS transcriptionally induces REDD1 expression in
macrophages.
3.2. LPS-induced REDD1 expression requires activation of p38MAPK,
but not NF-jB
LPS induces intracellular signal pathways to include NF-jB and
various MAPKs, such as the ERK1/2, JNK, and p38MAPK [1]. We
examined which signal mediators are involved in LPS-mediated
REDD1 expression using various chemical inhibitors. LPS-induced
increases in REDD1 mRNA and protein were effectively inhibited
by a p38MAPK inhibitor (SB203580), but not by inhibitors of
NF-jB (Bay11-7082), ERK1/2 (PD98059), and JNK (SP600125)
(Fig. 2A). We next examined the effects of these inhibitors on
REDD1 promoter activity. LPS-induced increases in REDD1 pro-
moter activity were dramatically inhibited by SB203580; however,
the effect of LPS was not affected by Bay11-7082, PD98059, and
SP600125 (Fig. 2B). As expected, Bay11-7082 effectively inhibited
NF-jB-responsive iNOS expression, nitric oxide production and
NF-jB-Luc activity, without affecting REDD1 expression, in a
dose-dependent manner in LPS-stimulated RAW264.7 cells
(Fig. 2C). Furthermore, similar results were also observed in the
NF-jB subunit p65 or c-Rel knockdown cells (Fig. 2D–G). These
results suggest that LPS-induced REDD1 expression requires acti-
vation of the p38MAPK-dependent signaling pathway, but not
the NF-jB pathway.
3.3. LPS-induced REDD1 expression is mediated by the p38MAPK-
dependent MSK1/CREB pathway
Since LPS promotes phosphorylation of MSK1 on Thr-581 via
activation of p38MAPK, leading to the transcription factor CREB
phosphorylation on Ser-133 [15,16], we examined the functional
role of MSK1 and CREB in LPS-induced REDD1 expression in macro-
phages. LPS treatment significantly increased phosphorylation of
p38MAPK, MSK1, and CREB in RAW264.7 cells, and MSK1 andCREB phosphorylation was inhibited in a dose-dependent manner
by the p38MAPK inhibitor SB203580 (Fig. 3A). As expected, this
inhibitor also abolished LPS-induced REDD1 expression in a dose-
dependent manner. Moreover, LPS-induced CREB phosphorylation
and REDD1 expression were dose-dependently inhibited by the
MSK1 inhibitor Ro318220 (Fig. 3B). Similar results were observed
following MSK1 knockdown in LPS-induced CREB phosphorylation
and REDD1 expression (Fig. 3C). These findings suggest that LPS
stimulates REDD1 expression by activation of the transcription fac-
tor CREB via the p38MAPK/MSK1 axis. Analysis of transcription
factor-binding motifs in the REDD1 promoter (1.5 kb) using
computer-based bioinformatics (www.cbrc.jp) revealed that the
promoter has some putative regulatory elements, including c-Rel,
C/EBP, and CREB, but not NF-jB (data not shown). This data sug-
gests that CREB is an important transcription factor in LPS-
mediated REDD1 expression. To confirm the involvement of CREB
in LPS-mediated induction of REDD1, we investigated whether
CREB binds to the CRE site of the REDD1 promoter by ChIP assay.
Treatment with LPS resulted in a significant increase in CREB bind-
ing to the REDD1 promoter region between 593 and 475.
Importantly, this binding was inhibited by treatment with
SB203580 and/or Ro318220 as well as MSK1 knockdown
(Fig. 3D). Moreover, LPS effectively increased transcriptional
activity of the REDD1 promoter, but not of the CRE-site mutant
promoter (Fig. 3E). These results suggest that LPS increases
REDD1 expression by activation of CREB via the p38MAPK/MSK1
pathway.
3.4. LPS-induced COX-2 elicits delayed expression of REDD1 via the
PGE2/PKA/CREB pathway
LPS induces COX-2 expression, leading to production of PGE2
that stimulates the cAMP/PKA/CREB pathway through EP2/4 recep-
tors [17]. Therefore, we examined whether LPS-induced COX-2
expression is involved in regulation of REDD1 expression.
Stimulation with LPS increased both REDD1 and COX-2 expression
at 4 h, but did not significantly elevate PGE2 levels (Fig. 4A and B).
Under the same experimental conditions, LPS-mediated increases
in REDD1 expression and CREB phosphorylation were not affected
by treatment with the COX-2 inhibitor NS398 or the PKA inhibitor
PKI (Fig. 4A). These results demonstrate that LPS-induced REDD1
expression is not regulated by the COX-2/cAMP/PKA pathway at
the early stage. We also examined whether LPS-induced COX-2 is
involved in delayed expression of REDD1 in macrophages. When
stimulated with LPS for 16 h, RAW264.7 cells significantly induced
COX-2 and REDD1 expression and CREB phosphorylation (Fig. 4C),
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tion and REDD1 expression was blocked by treatment with
NS398 and PKI, while PGE2 production was inhibited only by
NS398 (Fig. 4C and D). Moreover, treatment with PGE2 increased
transcriptional activity of REDD1 promoter, but not its CRE-sitemutant, as well as promoted CREB phosphorylation and REDD1
expression, and these increases were blocked by PKI
(Fig. 4E and F). These results suggest that LPS induces delayed
REDD1 expression via the COX-2/PGE2-mediated PKA/CREB
pathway.
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D.-K. Lee et al. / FEBS Letters 589 (2015) 2859–2865 28633.5. Db-cAMP increases REDD1 expression via the PKA/CREB pathway
We next examined the effects of the membrane permeable
cAMP analogue db-cAMP on REDD1 expression and promoter
activity. Treatment with db-cAMP increased CREB phosphoryla-
tion, REDD1 expression, and CREB binding to the CRE site of
REDD1 promoter, and these increases were blocked by PKI
(Fig. 5A–C). Furthermore, db-cAMP effectively increased transcrip-
tional activity of REDD1 promoter, but not its CRE-site mutant, and
this increase was blocked by PKI (Fig. 5D). These results suggest
that CREB is critically involved in REDD1 expression.4. Discussion
Although various cellular stresses transcriptionally induce
REDD1 expression [3–6], its inducible mechanism has not been
clearly studies in LPS-stimulated macrophages. In this study,
we examined whether LPS regulates REDD1 gene expression in
the murine macrophage RAW264.7 cells and murine peritoneal
macrophages. We found that LPS significantly increased REDD1
expression in both macrophages through two distinct CREB
activation mechanisms, the early p38MAPK/MSK1 pathway and
the delayed COX-2/PGE2-dependent cAMP/PKA pathway.
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There are several induction mechanisms of REDD1 in response
to diverse cellular stresses. An initial study demonstrated that
REDD1 was effectively induced in a p53-dependent manner in
response to ionizing radiation, indicating that REDD1 is a direct
transcriptional target of p53 [4]. In addition, Shoshani et al. showed
that REDD1/RTP801 was strongly induced in normal embryonic
stem (ES) cells, but not in HIF-1/ ES cells, under hypoxic condi-
tions. Moreover, this group identified a functional consensus motif
of hypoxia-responsive element at the positions 422 and 440 of
human and mouse DNAs, respectively [3]. Our recent study also
demonstrated that REDD1 expression is increased in the ischemic
CA1 region at an early time point after ischemic insult [18].
Therefore, it is clear that REDD1 is also a hypoxia-responsive target
gene. Moreover, a recent study revealed that cAMP plays an
important role in transcriptional REDD1 induction, clearly shown
by evidence that elevated intracellular cAMP resulting from
b2-adrenoceptor stimulation increased REDD1 expression in
macrophages [19]. This data suggests that REDD1 can be induced
via the cAMP-dependent signaling pathway.
We here found that LPS induces REDD1 expression in a
CREB-dependent manner. Moreover, we identified a functional
CREB-binding motif present at 573/566 in the REDD1 promoter.
Transcription activity of CREB is regulated through phosphoryla-
tion at serine-133 by several serine/threonine kinases, including
PKA, Ca2+-calmodulin-dependent kinase IV, and MSK [20]. LPS pro-
motes phosphorylation of CREB by the p38MAPK/MSK pathway
[15] and the COX-2 induction-mediated EP2/cAMP/PKA signaling
pathway [21]. Our data showed that REDD1 is induced in
LPS-stimulated macrophages by two distinct CREB phosphoryla-
tion pathways. At an early time point, LPS-stimulated CREB phos-
phorylation was elicited by p38MAPK-dependent MSK1
activation, which is not associated with PKA activity. However,
the delayed CREB activation coincided with the cAMP/PKA path-
way via COX-2-mediated PGE2 production. PGE2 exerts differential
and opposing effects on cellular functions depending on expression
levels of its receptor subtypes, EP1, EP2, EP2, and EP4, which differ in
their signal transduction pathways [17]. EP2/EP4 receptors are
highly expressed in macrophages, while EP1/EP3 receptor expres-
sion is negligible [22]. Ligation of EP2/EP4 receptors by PGE2
increases intracellular cAMP levels through activation of adenylyl
cyclase in macrophages, resulting in PKA-mediated CREB
phosphorylation [17]. Therefore, LPS induces REDD1 expression
in macrophages through PKA-dependent and -independent signal-
ing pathways.
Transcriptional activity of CREB is regulated by phosphor-
Ser133-dependent and -independent mechanisms, in concert with
the CREB-binding protein (CBP)/p300 coactivator and
CREB-regulated transcription coactivators (CRTCs), respectively
[23]. Our data showed that LPS increased MSK1-dependent CREB
phosphorylation and REDD1 expression, suggesting that
CBP/p300 plays an important role in CREB-responsive REDD1
expression in response to LPS. However, we did not examine the
involvement of CRTCs in LPS-induced CREB activation and REDD1
expression. Thus, we could not exclude the possibility that CRTCs
regulate LPS-mediated CREB activation and REDD1 expression,
and a further study should be conducted to verify the exact role
of CRTCs in REDD1 expression.
LPS is a strong activator of the NF-jB pathway, which induces
the expression of a wide variety of genes, including cytokine, che-
mokine and other inflammatory and survival genes [24]. However,
we found that the NF-jB inhibitor Bay11-7082 did not suppress
REDD1 expression in macrophages stimulated with LPS.
Moreover, specific knockdown of the NF-jB subunit p65 or c-Reldid not show any inhibitory effect on LPS-induced REDD1 expres-
sion. It suggests that REDD1 is not a NF-jB-responsive gene.
REDD1 is shown to exert multiple functions on cell survival and
growth, malignant transformation, tumor invasion, neuronal atro-
phy, and antiviral intervention by TSC1/TSC2-mediated inhibition
of mTOR [5,7,8,25,26]. Although a recent study showed that ele-
vated intracellular cAMP levels increase REDD1 expression in
macrophages [19], its function has not been defined. Chemical-
induced REDD1 reduces viral replication through inhibition of pro-
tein synthesis in virus-infected cells, similar to the mTOR inhibitor
rapamycin, suggesting that REDD1 is a new host defense factor
[26]. In fact, rapamycin inhibits LPS-induced IL-10 and IL-6 protein
levels in peripheral blood mononuclear cells [27], and LPS-induced
TNF-a expression was suppressed in REDD1/ mice [13]. These
observations suggest that REDD1 may to a certain extent play an
important role in immune and inflammatory responses via regula-
tion of mTOR activity. However, the coordination mechanism
between CREB-mediated REDD1 expression and inflammation
remains to be further investigated.
In summary, this work reports for the first time that LPS pro-
motes REDD1 expression in macrophages by two distinct CREB
activation axes, the early p38MAPK/MSK1 pathway and the
delayed cAMP/PKA pathway via COX-2-mediated PGE2 production.
Although we did not define the function of REDD1 in
LPS-stimulated macrophages, our data suggest that
CREB-mediated REDD1 induction may be involved in regulation
of inflammatory response, probably via TSC1/TSC2-mediated
inhibition of mTOR. We believe that further investigation of
CREB-mediated REDD1 functions will lead to new avenues for
the treatment of inflammation-associated diseases, including
sepsis and endotoxemia.
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